Unexpected Preferential Brain Metastases with a Human Breast Tumor Cell Line MDA-MB-231 in BALB/c Nude Mice

被引:7
|
作者
El-Mabhouh, A. A. [1 ]
Nation, P. N. [2 ]
Kaddoura, A. [3 ]
Mercer, J. R. [1 ,3 ]
机构
[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada
[2] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada
[3] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada
关键词
Animal models; experimental mammary neoplasms; mice; neoplasm metastasis;
D O I
10.1354/vp.45-6-941
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Animal models are useful tools to study etiology, progress, and new treatments of disease and are an approximation of human disease for experimental study. Intracardiac injection of the human estrogen-independent breast cancer cell line MDA-MB-231 in nude mice is a well-characterized animal model of bone metastasis mainly used to study new treatments for late-stage breast cancer. According to the published literature, this model should produce radiologically distinguishable bone tumors within 17 days after injection. Mice should develop complications such as cachexia, paraplegia, and morbidity within 28 days and require euthanasia within 35 days after injection. We report a study in which injection of MDA-MB-231 cell line led to brain rather than bone metastasis. Unexpected alterations in biological behavior are an important confounding variable in the use of tumor cell lines, and the occurrence and cause of such variants is poorly documented.
引用
收藏
页码:941 / 944
页数:4
相关论文
共 50 条
  • [31] Involvement of cell-cell and cell-matrix interactions in bone destruction induced by metastatic MDA-MB-231 human breast cancer cells in nude mice
    Hiroaki Nakamura
    Toru Hiraga
    Tadashi Ninomiya
    Akihiro Hosoya
    Noboru Fujisaki
    Toshiyuki Yoneda
    Hidehiro Ozawa
    Journal of Bone and Mineral Metabolism, 2008, 26 : 642 - 647
  • [32] Jacalin-Curcumin Complex Sensitizes the Breast Cancer MDA-MB-231 Cell Line
    Petrova, Lidiya
    Gergov, Nikolay
    Stoup, Marie
    Zapryanova, Silvina
    Van Damme, Els J. M.
    Lebegue, Nicolas
    Liberelle, Maxime
    Zasheva, Diana
    Bogoeva, Vanya
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (24)
  • [33] Bevacizumab induces inflammation in MDA-MB-231 breast cancer cell line and in a mouse model
    El-Hajjar, Layal
    Jalaleddine, Nour
    Shaito, Abdullah
    Zibara, Kazem
    Kazan, Jalal M.
    El-Saghir, Jamal
    El-Sabban, Marwan
    CELLULAR SIGNALLING, 2019, 53 : 400 - 412
  • [34] Cytotoxic and genotoxic effects of Bendiocarb on MDA-MB-231 cell line
    Gul, Derya
    Pandir, Dilek
    INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, 2024, 62 (12) : 949 - 957
  • [35] Ectophosphatase activity in the triple-negative breast cancer cell line MDA-MB-231
    Lacerda-Abreu, Marco A.
    Russo-Abrahao, Thais
    Leite Tenorio Aguiar, Raissa
    Monteiro, Robson de Queiroz
    Rumjanek, Franklin D.
    Meyer-Fernandes, Jose R.
    CELL BIOLOGY INTERNATIONAL, 2021, 45 (02) : 411 - 421
  • [36] The effect of osteopontin-siRNAs and irradiation in breast cancer cell line MDA-MB-231
    Hahnel, A.
    Wichmann, H.
    Kappler, M.
    Vordermark, D.
    Taubert, H.
    Bache, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 : 152 - 152
  • [37] Phenotypic and Functional Characterization of an Invasive Subpopulation of MDA-MB-231 Breast Cancer Cell Line
    Angelini, G.
    Amaro, A.
    Esposito, A.
    Maffei, M.
    Giaretti, W.
    Astigiano, S.
    Barbieri, O.
    Viale, M.
    Zunino, A.
    Pfeffer, U.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S100 - S100
  • [38] Data on cell cycle in breast cancer cell line, MDA-MB-231 with ferulic acid treatment
    Park, Eunmi
    DATA IN BRIEF, 2016, 7 : 107 - 110
  • [39] Intravenous infusions of TriN 2755, a new alkylating agent, inhibit the growth of human MDA-MB-231 breast tumor in nude rats
    de Boisferon, Marc Hillairet
    Koob, Zina
    Ludwig, Georg
    Barth, Wolfgang
    Bichat, Francis
    CANCER RESEARCH, 2011, 71
  • [40] The effects of terbium on the cellular accumulation of cisplatin in MDA-MB-231 human breast tumor cells
    Mack, KM
    Canada, RG
    Andrews, PA
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 39 (03) : 217 - 222